Global Health and Impact Investment: Triple I’s Collaborative Path Forward
CarbGeM Inc. (hereinafter “CarbGeM”) is pleased to announce that Masakazu Nakajima, CEO, participated as a panelist in the event “Global Health × Impact Investment: Triple I’s Collaborative Path Forward,” co-hosted by Triple I for Global Health and the Office of Healthcare Policy, Cabinet Secretariat, held in Tokyo in November 2025.
The Triple I (Impact Investment Initiative for Global Health) is a G7 initiative launched on the occasion of the G7 Hiroshima Summit. Since its inception, it has aimed to expand impact investment in the global health sector by fostering collaboration among diverse stakeholders including domestic and international companies, international organizations, investors, and policymakers.
The initiative began in 2023 with 37 partner institutions and has now grown to include over 115 partners, including CarbGeM. Through hosting side events at the World Economic Forum (Davos), World Health Assembly, and United Nations General Assembly, as well as participating in impact investment events worldwide, Triple I has worked to enhance awareness and engagement in impact investment for global health.
This event shared the achievements of Triple I over the past two years and showcased best practices from partner organizations, with the goal of further promoting recognition and participation among stakeholders—particularly Japanese institutions—and strengthening contributions to global health.
Additionally, the networking sessions encouraged collaboration between domestic companies, organizations, international institutions, and investors to enhance Japan’s global presence in the field of global health.
Triple I for Global Health Official Website: https://tripleiforgh.org/
CarbGeM introduced digital health and health-tech implementation cases within the global health domain, presenting models that leverage private-sector technology to address field-level challenges.
As a Triple I partner, the company shared case studies of public–private partnerships (PPP) in which its digital solutions have been socially implemented through collaboration with healthcare providers and government agencies.
The presentation highlighted how Japanese startups can contribute to the international health ecosystem.
CarbGeM’s initiatives contribute to improving efficiency, standardization, and workforce development in fields such as infectious disease testing and medical DX (digital transformation). The company also exchanged perspectives on the potential for expanding these initiatives across emerging markets in Asia.
CarbGeM will continue to strengthen collaboration with Triple I and other international networks to:
Through AI and digital technologies, CarbGeM is committed to advancing the visualization and efficiency in healthcare, contributing to improved global medical access and the development of public health worldwide.
